Securities Law Daily provides daily coverage of developments in the regulation of federal, state, and international securities and futures trading, with objective coverage of the...
Oct. 28 — Fitness device manufacturer Fitbit Inc. failed to persuade a federal judge to dismiss investors' claims it falsely touted the reliability of its heart rate tracking technology ( Robb v. Fitbit, Inc. , 2016 BL 359028, N.D. Cal., No. 3:16-cv-00151, 10/26/16 ).
Investors pointed to specific allegedly misleading statements and adequately pleaded that corporate executives were aware the devices didn't perform as represented, Judge Susan Illston of the U.S. District Court of the Northern District of California said Oct. 26.
According to the class, in October 2014, Fitbit announced its new proprietary PurePulse optical heart rate technology that purported to provide “continuous and automatic” wrist-based heart rate tracking. The company also allegedly touted the technology’s accuracy in subsequent press releases, offering materials, earnings calls and press interviews. Two new products, the Fitbit Charge HR and the Fitbit Surge, would feature the new technology.
Driven by sales of products with PurePulse technology, Fitbit’s revenues reached $1.858 billion in 2015, compared to $745.4 million the previous year.
The class alleged that since heart rate monitoring was the key feature of the company’s products, its accuracy was crucial to the success of the business. In reality, the investors said, the monitoring systems were “dangerously inaccurate” and created a risk of life-threatening overexertion.
Investors were first made aware of the equipment's flaws in January 2016 when a separate lawsuit and accuracy study were made public. Fitbit's stock price collapsed by 45.8 percent in the wake of the disclosures.
In allowing the suit to go forward, the court said the investors pointed to numerous statements in which Fitbit claimed its devices could track heart rates at a high degree of accuracy. The class relied on multiple and varying sources to allege that the devices couldn’t perform as promised and that is enough to survive a motion to dismiss, Illston said.
The court also found that the complaint established a plausible inference of scienter—culpable intent. It pointed to alleged statements by two Fitbit quality assurance employees indicating that company executives were aware of the inaccuracy of the PurePulse technology.
The class is represented by Pomerantz LLP, New York. Fitbit is represented by Morrison & Foerster LLP, San Francisco.
To contact the reporter on this story: Antoinette Gartrell in Washington at email@example.com
To contact the editor responsible for this story: Phyllis Diamond at firstname.lastname@example.org
Copyright © 2016 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)